查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1672124

全球生物银行市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Biobanking Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 148 Pages | 商品交期: 最快1-2个工作天内

价格

全球生物银行市场规模预计将从 2024 年的 38.4 亿美元成长到 2033 年的 107.3 亿美元，在 2026 年至 2033 年的预测期内，年复合成长率(CAGR) 将达到 12.07%。

随着研究和临床应用对生物样本和资料的需求不断增长，生物银行市场有望大幅成长。生物库透过提供各种生物材料（包括血液、组织和 DNA 样本）在支持生物医学研究方面发挥至关重要的作用。随着全球对个人化医疗和基因组学的关注度不断提高，对生物银行服务的需求预计将上升，使该市场实现强劲扩张。

此外，生物银行技术的进步正在推动市场创新。自动化样品处理、储存解决方案和资料管理系统的发展正在提高生物库的效率和可靠性。这些创新不仅提高了样本的完整性和可访问性，而且促进了生物库与高通量测序和生物资讯学等先进研究方法的结合。随着研究不断探索生物银行的新应用，在改善研究成果和合作的推动下，市场可能会进一步扩大。

此外，对道德考虑和法规遵从性的日益重视正在塑造生物银行的格局。随着生物库在样本收集和使用方面遵守复杂的道德框架和法规，对透明和合规的生物库实践的需求可能会增加。这一趋势在患者同意和资料隐私的背景下尤其重要，因为保持信任和透明度至关重要。随着生物银行市场不断发展，技术进步、道德考量和合作重点的结合将在塑造其未来发展轨迹方面发挥关键作用。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

  • 报告描述
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究流程
    • 市场研究方法

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：生物银行产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业趋势
  • 波特五力分析
  • 市场吸引力分析
    • 按产品和服务进行市场吸引力分析
    • 依样品类型进行市场吸引力分析
    • 按储存类型进行市场吸引力分析
    • 按所有权分類的市场吸引力分析
    • 市场吸引力分析：按应用
    • 最终用户的市场吸引力分析
    • 市场吸引力分析：按地区

第四章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料製造商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球生物银行市场分析：按产品和服务

  • 产品和服务概览
  • 按产品和服务进行的历史和预测数据分析
  • 设备（储存设备、样品分析设备、样品处理设备、样品运输设备）
  • 耗材（储存耗材、分析耗材、处理耗材、收集耗材）
  • 服务
  • 软体

第 6 章：全球生物银行市场分析：依样本类型

  • 样品类型概览
  • 按样本类型进行的历史和预测资料分析
  • 血液製品
  • 人体组织
  • 细胞系
  • 核酸
  • 生物体液
  • 人类废物

第 7 章：全球生物银行市场分析：按储存类型

  • 依储存类型概览
  • 按储存类型进行的历史和预测资料分析
  • 手动储存
  • 自动化存储

第 8 章：全球生物银行市场分析：按所有权划分

  • 所有权概览
  • 按所有权进行历史和预测资料分析
  • 大学
  • 国家/地区代理机构
  • 非营利组织
  • 私人组织

第 9 章：全球生物银行市场分析：按应用

  • 概述：按应用
  • 历史和预测数据分析：按应用
  • 再生医学
  • 生命科学研究
  • 临床研究

第 10 章：全球生物银行市场分析：按最终用户

  • 最终用户概览
  • 最终用户的历史和预测数据分析
  • 製药和生物技术公司及 CRO
  • 学术及研究机构
  • 医院

第 11 章：全球生物银行市场分析：按地区划分

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概述、历史和预测数据销售分析
    • 北美各细分市场销售分析
    • 北美各国销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测数据销售分析
    • 欧洲各细分市场销售分析
    • 欧洲各国销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测数据销售分析
    • 亚太地区分部销售分析
    • 亚太地区国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测数据销售分析
    • 拉丁美洲各细分市场销售分析
    • 拉丁美洲各国销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测数据销售分析
    • 中东和非洲分部销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东和非洲其他地区销售分析

第 12 章：生物银行公司的竞争格局

  • 生物银行市场竞争
  • 伙伴关係/合作/协议
  • 合併与收购
  • 新产品发布
  • 其他进展

第 13 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Merck KGaA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Becton
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dickinson And Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • PHC Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Avantor Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Greiner Holding AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Azenta Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Tecan Trading AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hamilton Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Cryoport Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Micronic
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • AMSBIO
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bay Biosciences LLC
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BioKryo
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • SPT Labtech
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Product Code: VMR11212372

Global Biobanking Market size is anticipated to grow from USD 3.84 Billion in 2024 to USD 10.73 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.07% during the forecast period of 2026 to 2033.

The biobanking market is poised for significant growth, driven by the increasing demand for biological samples and data for research and clinical applications. Biobanks play a crucial role in supporting biomedical research by providing access to a wide range of biological materials, including blood, tissue, and DNA samples. As the global focus on personalized medicine and genomics intensifies, the demand for biobanking services is expected to rise, positioning this market for robust expansion.

Moreover, advancements in biobanking technologies are driving innovation within the market. The development of automated sample processing, storage solutions, and data management systems is enhancing the efficiency and reliability of biobanks. These innovations not only improve sample integrity and accessibility but also facilitate the integration of biobanking with advanced research methodologies, such as high-throughput sequencing and bioinformatics. As research continues to explore new applications for biobanking, the market is likely to expand further, driven by the promise of improved research outcomes and collaboration.

Additionally, the growing emphasis on ethical considerations and regulatory compliance is shaping the biobanking landscape. As biobanks navigate complex ethical frameworks and regulations regarding sample collection and usage, the demand for transparent and compliant biobanking practices is likely to increase. This trend is particularly relevant in the context of patient consent and data privacy, where maintaining trust and transparency is essential. As the biobanking market continues to evolve, the combination of technological advancements, ethical considerations, and a focus on collaboration will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product &Service

  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables)
  • Services
  • Software

By Sample Type

  • Blood Products
  • Human Tissues
  • Cell Lines
  • Nucleic Acids
  • Biological Fluids
  • Human Waste Products

By Storage Type

  • Manual Storage
  • Automated Storage

By Ownership

  • Universities
  • National/Regional Agencies
  • Non-Profit Organizations
  • Private Organizations

By Application

  • Regenerative Medicine
  • Life Science Research
  • Clinical Research

By End user

  • Pharmaceutical & Biotechnology Companies and CROs
  • Academic & Research Institutes
  • Hospitals
  • COMPANIES PROFILED
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Becton
  • Dickinson and Company
  • PHC Holdings Corporation
  • Avantor Inc.
  • Greiner Holding AG
  • Azenta Inc.
  • Tecan Trading AG
  • Hamilton Company
  • Cryoport Inc.
  • Micronic
  • AMSBIO
  • Bay Biosciences LLC
  • BioKryo
  • SPT Labtech
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BIOBANKING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product &Service
    • 3.7.2 Market Attractiveness Analysis By Sample Type
    • 3.7.3 Market Attractiveness Analysis By Storage Type
    • 3.7.4 Market Attractiveness Analysis By Ownership
    • 3.7.5 Market Attractiveness Analysis By Application
    • 3.7.6 Market Attractiveness Analysis By End user
    • 3.7.7 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BIOBANKING MARKET ANALYSIS BY PRODUCT &SERVICE

  • 5.1. Overview By Product &Service
  • 5.2. Historical and Forecast Data Analysis By Product &Service
  • 5.3. Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Historic and Forecast Sales By Regions
  • 5.4. Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Historic and Forecast Sales By Regions
  • 5.5. Services Historic and Forecast Sales By Regions
  • 5.6. Software Historic and Forecast Sales By Regions

6. GLOBAL BIOBANKING MARKET ANALYSIS BY SAMPLE TYPE

  • 6.1. Overview By Sample Type
  • 6.2. Historical and Forecast Data Analysis By Sample Type
  • 6.3. Blood Products Historic and Forecast Sales By Regions
  • 6.4. Human Tissues Historic and Forecast Sales By Regions
  • 6.5. Cell Lines Historic and Forecast Sales By Regions
  • 6.6. Nucleic Acids Historic and Forecast Sales By Regions
  • 6.7. Biological Fluids Historic and Forecast Sales By Regions
  • 6.8. Human Waste Products Historic and Forecast Sales By Regions

7. GLOBAL BIOBANKING MARKET ANALYSIS BY STORAGE TYPE

  • 7.1. Overview By Storage Type
  • 7.2. Historical and Forecast Data Analysis By Storage Type
  • 7.3. Manual Storage Historic and Forecast Sales By Regions
  • 7.4. Automated Storage Historic and Forecast Sales By Regions

8. GLOBAL BIOBANKING MARKET ANALYSIS BY OWNERSHIP

  • 8.1. Overview By Ownership
  • 8.2. Historical and Forecast Data Analysis By Ownership
  • 8.3. Universities Historic and Forecast Sales By Regions
  • 8.4. National/Regional Agencies Historic and Forecast Sales By Regions
  • 8.5. Non-Profit Organizations Historic and Forecast Sales By Regions
  • 8.6. Private Organizations Historic and Forecast Sales By Regions

9. GLOBAL BIOBANKING MARKET ANALYSIS BY APPLICATION

  • 9.1. Overview By Application
  • 9.2. Historical and Forecast Data Analysis By Application
  • 9.3. Regenerative Medicine Historic and Forecast Sales By Regions
  • 9.4. Life Science Research Historic and Forecast Sales By Regions
  • 9.5. Clinical Research Historic and Forecast Sales By Regions

10. GLOBAL BIOBANKING MARKET ANALYSIS BY END USER

  • 10.1. Overview By End user
  • 10.2. Historical and Forecast Data Analysis By End user
  • 10.3. Pharmaceutical & Biotechnology Companies and CROs Historic and Forecast Sales By Regions
  • 10.4. Academic & Research Institutes Historic and Forecast Sales By Regions
  • 10.5. Hospitals Historic and Forecast Sales By Regions

11. GLOBAL BIOBANKING MARKET ANALYSIS BY GEOGRAPHY

  • 11.1. Regional Outlook
  • 11.2. Introduction
  • 11.3. North America Sales Analysis
    • 11.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.3.2 North America By Segment Sales Analysis
    • 11.3.3 North America By Country Sales Analysis
    • 11.3.4 United States Sales Analysis
    • 11.3.5 Canada Sales Analysis
    • 11.3.6 Mexico Sales Analysis
  • 11.4. Europe Sales Analysis
    • 11.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.4.2 Europe By Segment Sales Analysis
    • 11.4.3 Europe By Country Sales Analysis
    • 11.4.4 United Kingdom Sales Analysis
    • 11.4.5 France Sales Analysis
    • 11.4.6 Germany Sales Analysis
    • 11.4.7 Italy Sales Analysis
    • 11.4.8 Russia Sales Analysis
    • 11.4.9 Rest Of Europe Sales Analysis
  • 11.5. Asia Pacific Sales Analysis
    • 11.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.5.2 Asia Pacific By Segment Sales Analysis
    • 11.5.3 Asia Pacific By Country Sales Analysis
    • 11.5.4 China Sales Analysis
    • 11.5.5 India Sales Analysis
    • 11.5.6 Japan Sales Analysis
    • 11.5.7 South Korea Sales Analysis
    • 11.5.8 Australia Sales Analysis
    • 11.5.9 South East Asia Sales Analysis
    • 11.5.10 Rest Of Asia Pacific Sales Analysis
  • 11.6. Latin America Sales Analysis
    • 11.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.6.2 Latin America By Segment Sales Analysis
    • 11.6.3 Latin America By Country Sales Analysis
    • 11.6.4 Brazil Sales Analysis
    • 11.6.5 Argentina Sales Analysis
    • 11.6.6 Peru Sales Analysis
    • 11.6.7 Chile Sales Analysis
    • 11.6.8 Rest of Latin America Sales Analysis
  • 11.7. Middle East & Africa Sales Analysis
    • 11.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 11.7.2 Middle East & Africa By Segment Sales Analysis
    • 11.7.3 Middle East & Africa By Country Sales Analysis
    • 11.7.4 Saudi Arabia Sales Analysis
    • 11.7.5 UAE Sales Analysis
    • 11.7.6 Israel Sales Analysis
    • 11.7.7 South Africa Sales Analysis
    • 11.7.8 Rest Of Middle East And Africa Sales Analysis

12. COMPETITIVE LANDSCAPE OF THE BIOBANKING COMPANIES

  • 12.1. Biobanking Market Competition
  • 12.2. Partnership/Collaboration/Agreement
  • 12.3. Merger And Acquisitions
  • 12.4. New Product Launch
  • 12.5. Other Developments

13. COMPANY PROFILES OF BIOBANKING INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Market Concentration Rate
  • 13.3. Merck KGaA
    • 13.3.1 Company Overview
    • 13.3.2 Company Revenue
    • 13.3.3 Products
    • 13.3.4 Recent Developments
  • 13.4. Thermo Fisher Scientific Inc.
    • 13.4.1 Company Overview
    • 13.4.2 Company Revenue
    • 13.4.3 Products
    • 13.4.4 Recent Developments
  • 13.5. Becton
    • 13.5.1 Company Overview
    • 13.5.2 Company Revenue
    • 13.5.3 Products
    • 13.5.4 Recent Developments
  • 13.6. Dickinson And Company
    • 13.6.1 Company Overview
    • 13.6.2 Company Revenue
    • 13.6.3 Products
    • 13.6.4 Recent Developments
  • 13.7. PHC Holdings Corporation
    • 13.7.1 Company Overview
    • 13.7.2 Company Revenue
    • 13.7.3 Products
    • 13.7.4 Recent Developments
  • 13.8. Avantor Inc.
    • 13.8.1 Company Overview
    • 13.8.2 Company Revenue
    • 13.8.3 Products
    • 13.8.4 Recent Developments
  • 13.9. Greiner Holding AG
    • 13.9.1 Company Overview
    • 13.9.2 Company Revenue
    • 13.9.3 Products
    • 13.9.4 Recent Developments
  • 13.10. Azenta Inc.
    • 13.10.1 Company Overview
    • 13.10.2 Company Revenue
    • 13.10.3 Products
    • 13.10.4 Recent Developments
  • 13.11. Tecan Trading AG
    • 13.11.1 Company Overview
    • 13.11.2 Company Revenue
    • 13.11.3 Products
    • 13.11.4 Recent Developments
  • 13.12. Hamilton Company
    • 13.12.1 Company Overview
    • 13.12.2 Company Revenue
    • 13.12.3 Products
    • 13.12.4 Recent Developments
  • 13.13. Cryoport Inc.
    • 13.13.1 Company Overview
    • 13.13.2 Company Revenue
    • 13.13.3 Products
    • 13.13.4 Recent Developments
  • 13.14. Micronic
    • 13.14.1 Company Overview
    • 13.14.2 Company Revenue
    • 13.14.3 Products
    • 13.14.4 Recent Developments
  • 13.15. AMSBIO
    • 13.15.1 Company Overview
    • 13.15.2 Company Revenue
    • 13.15.3 Products
    • 13.15.4 Recent Developments
  • 13.16. Bay Biosciences LLC
    • 13.16.1 Company Overview
    • 13.16.2 Company Revenue
    • 13.16.3 Products
    • 13.16.4 Recent Developments
  • 13.17. BioKryo
    • 13.17.1 Company Overview
    • 13.17.2 Company Revenue
    • 13.17.3 Products
    • 13.17.4 Recent Developments
  • 13.18. SPT Labtech
    • 13.18.1 Company Overview
    • 13.18.2 Company Revenue
    • 13.18.3 Products
    • 13.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Biobanking Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Biobanking Report
  • Market Research Process
  • Market Research Methodology
  • Global Biobanking Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product &Service
  • Market Attractiveness Analysis By Sample Type
  • Market Attractiveness Analysis By Storage Type
  • Market Attractiveness Analysis By Ownership
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End user
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product &Service (USD MN)
  • Equipment (Storage Equipment, Sample Analysis Equipment, Sample Processing Equipment, Sample Transport Equipment) Market Sales By Geography (USD MN)
  • Consumables (Storage Consumables, Analysis Consumables, Processing Consumables, Collection Consumables) Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Software Market Sales By Geography (USD MN)
  • Global Market Analysis By Sample Type (USD MN)
  • Blood Products Market Sales By Geography (USD MN)
  • Human Tissues Market Sales By Geography (USD MN)
  • Cell Lines Market Sales By Geography (USD MN)
  • Nucleic Acids Market Sales By Geography (USD MN)
  • Biological Fluids Market Sales By Geography (USD MN)
  • Human Waste Products Market Sales By Geography (USD MN)
  • Global Market Analysis By Storage Type (USD MN)
  • Manual Storage Market Sales By Geography (USD MN)
  • Automated Storage Market Sales By Geography (USD MN)
  • Global Market Analysis By Ownership (USD MN)
  • Universities Market Sales By Geography (USD MN)
  • National/Regional Agencies Market Sales By Geography (USD MN)
  • Non-Profit Organizations Market Sales By Geography (USD MN)
  • Private Organizations Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Regenerative Medicine Market Sales By Geography (USD MN)
  • Life Science Research Market Sales By Geography (USD MN)
  • Clinical Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End user (USD MN)
  • Pharmaceutical & Biotechnology Companies and CROs Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.